Fundz

Kaveri Therapeutics, a US-based spinout from Lupin, has secured $1.6 million in seed funding for clinical development of cancer therapies with plans for additional capital.

PRIVATEJul 21, 2026

Amount Raised

$1.6 Million

Round Type

Seed

IndiaBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

Lupin has spun out Kaveri Therapeutics, providing the startup with two clinical-phase cancer drug candidates and $1.6 million in seed funding. Kaveri plans to use the funds for further development of these therapies. Kaveri aims to raise additional capital for clinical development of the assets. Kristi Jones has been appointed CEO to lead the new venture.

Quick answer

Kaveri Therapeutics raised $1.6 Million in a Seed round, dated July 21, 2026. Kaveri Therapeutics is based in India.

How much did Kaveri Therapeutics raise?
Kaveri Therapeutics raised $1.6 Million in a Seed round on July 21, 2026.
What does Kaveri Therapeutics do?
Kaveri Therapeutics is a U.S.-based startup focused on developing cancer therapies.
Where is Kaveri Therapeutics based and how big is it?
Kaveri Therapeutics is based in India.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Kaveri Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Dimerix Limited raised $25M (Debt Financing) on September 4, 2026.
  • N-Power Medicine raised $32M (Series B) on September 1, 2026.
  • Redx raised $36M (Series A) on August 27, 2026.
  • Amylyx Pharmaceuticals raised $500M (Post-IPO Equity) on August 20, 2026.
  • Apollomics raised $10M on August 14, 2026.
  • Vaderis Therapeutics raised $152M (Series B) on August 11, 2026.

Who to call at Kaveri Therapeutics, and when

A new round usually means Kaveri Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Kaveri Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kaveri Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kaveri Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kaveri Therapeutics

Location

India

About

Kaveri Therapeutics is a U.S.-based startup focused on developing cancer therapies. It has spun out two clinical-phase drug candidates, targeting critical areas pursued by leading biopharmaceutical companies. The company is led by experienced executives and aims to secure funding for further clinical development of its innovative assets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kaveri Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Kaveri Therapeutics's next move

See what Strategic adds

Kaveri Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.